1. NCCN. https://www.nccn.org/professionals/physician_gls/ . Accessed on 09 April 2019.
2. Ananthakrishnan A, Gogineni V, Saeian K. Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol. 2006;23:47–63.
3. Kew MC. Hepatic tumors and cysts. In: Felman M, Friedman LS, Sleisenger MH, Scharschmidt BF, editors. Sleisenger and Fordtrans’s gastrointestinal and liver disease: pathophysiology/diangosis/management. 7th ed. Philadelphia: Saunders; 2002. p. 1589.
4. Surveillance Eepidemiology and End Results Program (SEER), National Cancer Institute. Cancer Stat Facts: Liver and intrahepatic bile duct cancer 2019. https://seer.cancer.gov/statfacts/html/livibd.html . Accessed on 09 April 2019.
5. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–6. https://doi.org/10.1053/gast.2003.50016 .